Skip to main navigation Skip to search Skip to main content

Long-term safety profile of siplizumab, a humanized anti-CD2 monoclonal antibody, in subjects with chronic plaque psoriasis

  • Barbara White
  • , Brian Harris

Research output: Contribution to journal › Article › peer-review

1   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Long-term safety profile of siplizumab, a humanized anti-CD2 monoclonal antibody, in subjects with chronic plaque psoriasis'. Together they form a unique fingerprint.
Sort by

Keyphrases

Immunology and Microbiology

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science